Zheng Quan Zhi Xing·2025-05-22 14:23Core Viewpoint - JOINN Laboratories (China) Co., Ltd. has announced the further subscription of structured deposit products from Jiangsu Bank, totaling RMB 440 million, which is expected to yield reasonable interest without adversely affecting the company's financial situation [1][5]. Summary by Sections Subscription of Financial Products - The company has subscribed to four structured deposit products from Jiangsu Bank, with the total investment amounting to RMB 440 million [1][4]. - The first product has an investment of RMB 150 million with an expected annual return rate of 0.1%–2.45%, maturing on May 22, 2025 [4]. - The second product involves an investment of RMB 60 million with an expected annual return rate of 1.60%–2.50%, maturing on December 27, 2025 [4]. - The third product has an investment of RMB 200 million with an expected annual return rate of 1.00%–2.56%, maturing on August 26, 2025 [4]. - The fourth product involves an investment of RMB 30 million with an expected annual return rate of 1.50% or 2.45%, maturing on November 23, 2025 [4]. Current Status - As of the announcement date, the company confirmed that all previously subscribed financial products have been redeemed according to their terms, except for the structured deposit products from Jiangsu Bank [5]. - The company believes that the structured deposit products will yield reasonable interest and will not negatively impact its financial condition [5]. Reasoning and Benefits for Subscription - The company aims to utilize excess cash in its capital account without affecting operational liquidity by subscribing to these structured deposit products, which offer higher interest rates compared to regular bank deposits [5]. - The structured deposit products are considered low-risk and are expected to provide better returns than typical commercial bank deposits in China [5].